Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review.

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF) is a severe interstitial lung disease; although the recent introduction of two anti-fibrosis drugs, pirfenidone and Nidanib, have resulted in a significant reduction in lung function decline, IPF is still not curable. Approximately 2-20% of patients with IPF have a family history of the disease, which is considered the strongest risk factor for idiopathic interstitial...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA Fingerprinting
• Share to Genetic Predisposition to Disease